Skip to main content
Loading
Create Account
Cart
Toggle navigation
Keyword Search
Sign In/Account
Conferences
Toggle
Conference List
Past Meetings
How to Register
Invitation Letter
Submit an Abstract
Poster Display Guidelines
View Abstracts
Cancellations and Transfers
Order an Abstract Booklet
Submit a Conference Concept
Why Participate?
Virtual Keystone Symposia
Financial Aid
Toggle
Student Discounts
Scholarships
Underrepresented Trainee Scholarships
Global Health Travel Awards
Fellows Program
Early-Career Travel Awards
Support Us
Toggle
Donate as a Corporation
Donate as an Individual
Donate as a Foundation
Fund a Fellow
Future of Science Fund
Honor Mentor or Loved One
Current Donors
Gift-in-Kind Media Partners
Contact Development Office
Diversity
Toggle
Career Development Initiatives
Health Disparities Workshops
Fellows Program
Fellows Directory
Underrepresented Trainee Scholarships
Global Health Travel Awards
Early-Career Travel Awards
About
Toggle
Mission and History
Governance
Policies
Contact Us
Join Our Mailing List
Employment Opportunities
Letter From the CEO
Resources
Toggle
Frequently Asked Questions
Attendee Checklist
What to Expect/Bring
Travel Tips and Links
Special Needs
Roommate Bulletin Board
Childcare Bulletin Board
KS Connect App
Loading
This meeting took place in the past. Here is a list of meetings that are related:
Tumor Metabolism (2022J2)
Tumor Metabolism (2019B5)
Tumor Metabolism (2018A5)
Tumor Metabolism: Mechanisms and Targets (2017X3)
New Frontiers in Understanding Tumor Metabolism (2016Q7)
Integrating Metabolism and Tumor Biology (2015J1)
Tumor Metabolism (2014X6)
Loading
Web Desc
Tumor Metabolism
joint with PI 3-Kinase and Interplay with Other Signaling Pathways
Organizer(s): Matthew G. Vander Heiden and Karen H. Vousden
Date: February 24 - March 01, 2013
Location: Keystone Resort, Keystone, CO, USA
Sponsored by AVEO Oncology and Bayer USA Foundation
For important information on the coronavirus, please
click here
Summary of Meeting:
Proliferating tumor cells have different metabolic requirements than most normal differentiated cells. All cells consume nutrients to generate ATP and maintain homeostasis, however cell proliferation requires additional nutrient uptake to support macromolecular synthesis needed for cell growth. How metabolic pathways are regulated to balance these needs is not well understood, but mounting evidence suggests that metabolism is actively regulated to support cell growth, and that this regulation is intimately linked with the signal transduction pathways that control cell growth and proliferation. Metabolic changes represent some of the first differences ever noted between tumors and normal tissues. Yet, only recently has it been appreciated that many genetic events associated with cancer result in signal transduction changes to promote metabolism that is conducive to growth. This has accelerated research to understand metabolism in tumors with an eye toward targeting these pathways for improved cancer therapy. Substantial progress in the field has come from laboratories with diverse expertise providing new insights about metabolism and its regulation. However, a deeper understanding of tumor metabolism requires methods to assess metabolite flux and pathway regulation that historically have not been used to study cancer biology. Recent years have seen a remarkable advance in techniques available to interrogate metabolic pathways in vitro and in vivo. This work has been augmented by progress in modeling metabolic networks that facilitate interpretation of complex metabolism data to define key points of regulation. A growing cross talk between these systems biology approaches and traditional cancer biology studies has enabled increasingly sophisticated studies that enhance our understanding of tumor metabolism. Bringing together scientists with expertise in signal transduction, nutrient and oxygen sensing, genetic events affecting metabolism, metabolic flux measurements and network modeling will provide an opportunity to discuss the latest data informing metabolic regulation in tumors. These discussions will impact studies of metabolism in other contexts. Similarly, emerging data related to metabolic regulation in the immune systems can inform studies of tumor metabolism. PI-3 kinase is a critical regulator of metabolism and there have been numerous advances in understanding this signaling pathway; a joint meeting addressing PI-3 Kinase will enrich the dialogue across disciplines to explore how metabolism influences multiple aspects of biology.
Scholarship Deadline: October 25 2012
Discounted Abstract Deadline: October 25 2012
Abstract Deadline: November 28 2012
Discounted Registration Deadline: December 19 2012
Abstacts when book is in proofing process
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Piramal Imaging GmbH
We gratefully acknowledge the generous grant for this conference provided by:
National Cancer Institute (NCI)
Grant No. 1R13CA174034-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
Program
Loading
Sunday, February 24
| 3:00PM - 7:30PM
Arrival and Registration
Room: Longs Peak Foyer
Sunday, February 24
| 6:15PM - 7:15PM
Refreshments
Room: Longs Peak Foyer
Monday, February 25
| 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak
Monday, February 25
| 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Longs Peak
Speaker 1 of 2
* Matthew G. Vander Heiden
, Massachusetts Institute of Technology, USA
Monday, February 25
| 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Longs Peak
Speaker 2 of 2
Craig B. Thompson
, Memorial Sloan Kettering Cancer Center, USA
Metabolic Control of Tumor Cell Growth and Survival
Monday, February 25
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical - Part 1)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 5
* José Baselga
, Memorial Sloan-Kettering Cancer Center, USA
Breast Cancer
Monday, February 25
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical - Part 1)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 5
Brett S. Carver
, USA
Targeting the PI3K and AR Pathways in Prostate Cancer: Defining Mechanisms of Response and Resistance
Monday, February 25
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical - Part 1)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 5
Vito J. Palombella
, USA
Development of the Potent PI3K-delta,gamma Inhibitor IPI-145
Monday, February 25
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical - Part 1)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 5
Khaled Ali
, Barts Cancer Institute, UK
Short Talk: Inactivation of p110delta PI 3-Kinase Releases Anti-Tumor Immune Responses
Monday, February 25
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical - Part 1)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 5 of 5
Kyle A. Edgar
, Genentech, Inc., USA
Short Talk: Mechanisms of Acquired Resistance to the PI3K Inhibitor, GDC-0941 in Colorectal Cancer Cell Lines
Monday, February 25
| 9:00AM - 11:00AM
Metabolic Regulation
Room: Longs Peak
Speaker 1 of 5
* Karen H. Vousden
, Francis Crick Institute, UK
Monday, February 25
| 9:00AM - 11:00AM
Metabolic Regulation
Room: Longs Peak
Speaker 2 of 5
Almut Schulze
, University of Würzburg/Theodor-Boveri Institute, Germany
The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells
Monday, February 25
| 9:00AM - 11:00AM
Metabolic Regulation
Room: Longs Peak
Speaker 3 of 5
Linda Z. Penn
, Princess Margaret Cancer Centre, Canada
The Mevalonate Pathway, Signaling and Tumor Vulnerability
Monday, February 25
| 9:00AM - 11:00AM
Metabolic Regulation
Room: Longs Peak
Speaker 4 of 5
Daniel S. Peeper
, Netherlands Cancer Institute, Netherlands
Short Talk: A Critical Role for the Mitochondrial Gatekeeper Pyruvate Dehydrogenase in Oncogene-Induced Senescence
Monday, February 25
| 9:00AM - 11:00AM
Metabolic Regulation
Room: Longs Peak
Speaker 5 of 5
Jing Chen
, Winship Cancer Institute, Emory University, USA
Short Talk: Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
Monday, February 25
| 9:40AM - 10:00AM
Coffee Break
Room: Longs Peak Foyer
Monday, February 25
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Monday, February 25
| 11:00AM - 1:00PM
Poster Setup
Room: Quandary Peak
Monday, February 25
| 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 1 of 7
* Matthew G. Vander Heiden
, Massachusetts Institute of Technology, USA
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 2 of 7
Ji Zhang
, Indiana University, USA
Why Cancer Cells Die without Glutamine?
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 3 of 7
Brandon N. Nicolay
, Agios Pharmaceuticals, USA
Loss of RBF1 Changes Glutamine Catabolism
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 4 of 7
Ming Yang
, Beatson Institute for Cancer Research, UK
Candidate Roles for Protein Succination in Altered Metabolism and Oncogenesis
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 5 of 7
Talya L. Dayton
, Massachusetts Institute of Technology, USA
Elucidating a Role for Pkm Isoform Expression Specificity in vivo
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 6 of 7
Darin Salloum
, Memorial Sloan Kettering Cancer Center, USA
Human Cancer Cells Harboring Ras Mutations Display Elevated Requirement for Serum Lipids
Monday, February 25
| 2:30PM - 4:30PM
Workshop 1: Metabolic Regulation and Adaptation
Room: Longs Peak
Speaker 7 of 7
Wei Liu
, Frederick National Laboratory for Cancer Research, National Institutes of Health, USA
Proline Biosynthesis Augments MYC-Induced Aerobic Glycolysis and Cell Growth
Monday, February 25
| 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer
Monday, February 25
| 5:00PM - 7:00PM
Nutrient Sensing
Room: Longs Peak
Speaker 1 of 5
* Joan S. Brugge
, Harvard Medical School, USA
Monday, February 25
| 5:00PM - 7:00PM
Nutrient Sensing
Room: Longs Peak
Speaker 2 of 5
Eileen P. White
, Rutgers University, USA
Autophagy Maintains Mitochondrial Function and Tumorigenesis
Monday, February 25
| 5:00PM - 7:00PM
Nutrient Sensing
Room: Longs Peak
Speaker 3 of 5
Matthew G. Vander Heiden
, Massachusetts Institute of Technology, USA
Metabolic Pathways Important for Cell Growth
Monday, February 25
| 5:00PM - 7:00PM
Nutrient Sensing
Room: Longs Peak
Speaker 4 of 5
David M. Sabatini
, Whitehead Institute for Biomedical Research, USA
Large-Scale Approaches to Study Cancer Metabolism
Monday, February 25
| 5:00PM - 7:00PM
Nutrient Sensing
Room: Longs Peak
Speaker 5 of 5
Issam Ben-Sahra
, Northwestern University, USA
Short Talk: Growth Signaling Stimulates Nucleotide Synthesis through mTOR
Monday, February 25
| 5:00PM - 7:00PM
PI3K/Akt/mTOR Pathway (Clinical - Part 2)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 4
Neal Rosen
, Memorial Sloan-Kettering Cancer Center, USA
Interplay Signaling
Monday, February 25
| 5:00PM - 7:00PM
PI3K/Akt/mTOR Pathway (Clinical - Part 2)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 4
Kui Lin
, Genentech, Inc., USA
Akt
Monday, February 25
| 5:00PM - 7:00PM
PI3K/Akt/mTOR Pathway (Clinical - Part 2)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 4
Mark G. Manfredi
, Raze Therapeutics, USA
The Development of MLN0128, an Investigational mTOR Active Site Inhibitor
Monday, February 25
| 5:00PM - 7:00PM
PI3K/Akt/mTOR Pathway (Clinical - Part 2)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 4
Kathryn Balmanno
, Babraham Institute, UK
Short Talk: Modelling Acquired Resistance to mTOR Kinase Inhibitors
Monday, February 25
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak
Monday, February 25
| 7:30PM - 10:00PM
Poster Session 1
Room: Quandary Peak
Tuesday, February 26
| 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 1 of 7
* David M. Sabatini
, Whitehead Institute for Biomedical Research, USA
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 2 of 7
Brian J. Altman
, University of Rochester, USA
Regulation of Cell Growth and Metabolism by Myc
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 3 of 7
Karen H. Vousden
, Francis Crick Institute, UK
The Role of p53 in Metabolic Adaptation and Survival
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 4 of 7
Zachary Schug
, Wistar Institute, USA
Targeting Lipid Metabolism in Breast Cancer
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 5 of 7
Reuben J. Shaw
, The Salk Institute for Biological Studies, USA
The LKB1 Tumor Suppressor Pathway: Decoding Metabolic Links and Therapeutic Targeting
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 6 of 7
Costas A. Lyssiotis
, University of Michigan, USA
Short Talk: Glutamine Metabolism Supports Pancreatic Tumor Growth and Redox Homeostasis
Tuesday, February 26
| 8:00AM - 11:15AM
Metabolic Adaptation
Room: Longs Peak
Speaker 7 of 7
Zhimin Lu
, University of Texas MD Anderson Cancer Center, USA
Short Talk: The Warburg Effect and Beyond
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 6
* Jeffrey A. Engelman
, Novartis Institutes for BioMedical Research, USA
Resistance Mechanisms
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 6
Sebastian M. B. Nijman
, CeMM, Austrian Academy of Sciences, Austria
Gene-Drug Interaction Screens in Cancer
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 6
* Lori Friedman
, ORIC Pharmaceuticals, USA
PI3K Inhibitor Combination Therapies
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 6
Jonathan M. Backer
, Albert Einstein College of Medicine, USA
GPCR–Mediated Activation of p110beta by Gbetagamma Is Required for Cellular Transformation and Invasiveness
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 5 of 6
Wayne A. Phillips
, Peter MacCallum Cancer Centre, Australia
Short Talk: Ubiquitous Expression of a Heterozygous Pik3ca Mutation Results in Increased Body Size, Hypoglycemia and Sudden Death
Tuesday, February 26
| 8:00AM - 11:15AM
PI3K/Akt/mTOR Pathway in Cancer (Clinical Translational)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 6 of 6
Mamatha Bhat
, University Health Network, Canada
Short Talk: Metformin Induces Apoptosis of Hepatocellular Carcinoma Downstream of mTORC1 through eIF4E
Tuesday, February 26
| 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer
Tuesday, February 26
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Tuesday, February 26
| 11:00AM - 1:00PM
Poster Setup
Room: Quandary Peak
Tuesday, February 26
| 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak
Tuesday, February 26
| 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer
Tuesday, February 26
| 5:00PM - 7:00PM
Understanding the Metabolic Network
Room: Longs Peak
Speaker 1 of 5
* Ralph J. DeBerardinis
, University of Texas Southwestern Medical Center, USA
Tuesday, February 26
| 5:00PM - 7:00PM
Understanding the Metabolic Network
Room: Longs Peak
Speaker 2 of 5
Tomer Shlomi
, Technion, Israel
An Integrated Computational-Experimental Approach for Finding Metabolic Synthetic Lethality in Cancer
Tuesday, February 26
| 5:00PM - 7:00PM
Understanding the Metabolic Network
Room: Longs Peak
Speaker 3 of 5
Joshua D. Rabinowitz
, Princeton University, USA
Revealing Cancer Metabolism with Isotope Tracers
Tuesday, February 26
| 5:00PM - 7:00PM
Understanding the Metabolic Network
Room: Longs Peak
Speaker 4 of 5
Linda C. Hsieh-Wilson
, California Institute of Technology, USA
Linking O-GlcNAc Signaling to Cancer Metabolism and Tumor Growth
Tuesday, February 26
| 5:00PM - 7:00PM
Understanding the Metabolic Network
Room: Longs Peak
Speaker 5 of 5
Stefan Kempa
, Max Delbrück Center for Molecular Medicine, Germany
Short Talk: Quantifying Metabolic Routes in Cancer Cells Using Pulsed Stable Isotope Resolved Metabolomics (pSIRM)
Tuesday, February 26
| 5:00PM - 7:00PM
PI3K/mTOR Pathway - Signaling Networks (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 4
*
Kevan M. Shokat
, University of California, San Francisco, USA
Chemical Genetic Investigations of Protein and Lipid Kinase Signaling
Tuesday, February 26
| 5:00PM - 7:00PM
PI3K/mTOR Pathway - Signaling Networks (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 4
John Blenis
, Weill Cornell Medical College, USA
Convergence and Integration of mTOR and Ras-ERK Signaling in Cancer
Tuesday, February 26
| 5:00PM - 7:00PM
PI3K/mTOR Pathway - Signaling Networks (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 4
David M. Sabatini
, Whitehead Institute for Biomedical Research, USA
Regulation of Growth by the mTOR Pathway
Tuesday, February 26
| 5:00PM - 7:00PM
PI3K/mTOR Pathway - Signaling Networks (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 4
Tamara Chessa
, Babraham Institute, UK
Short Talk: Dissecting the ClassIA PI3K Signalosome
Tuesday, February 26
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak
Tuesday, February 26
| 7:30PM - 10:00PM
Poster Session 2
Room: Quandary Peak
Wednesday, February 27
| 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 1 of 6
* Sally A. Kornbluth
, Duke University Medical Center, USA
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 2 of 6
Jacques Pouysségur
, University of Nice, France
Hypoxia Signaling, pHi Regulation and Tumor Metabolism: Novel Therapeutic Approaches
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 3 of 6
M. Celeste Simon
, University of Pennsylvania, USA
Tumor Cell Adaptation to the Microenvironment
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 4 of 6
Amato J. Giaccia
, Stanford University, USA
Oxygen Sensing and Metabolic Control
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 5 of 6
Brendan D. Manning
, Harvard School of Public Health, USA
Tumor Cell Intrinsic Biosynthesis Driven by mTOR Signaling
Wednesday, February 27
| 8:00AM - 11:00AM
Influence of the Microenvironment on Metabolism
Room: Longs Peak
Speaker 6 of 6
Russell G. Jones
, Van Andel Research Institute, USA
Short Talk: AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth in vivo
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 6
* Lewis C. Cantley
, Weill Cornell Medicine, USA
PI 3-Kinase, AMPK and Disease
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 6
Judith A. Varner
, University of California, San Diego, USA
PI3K gamma Control of Innate Immunity in Cancer
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 6
Karen M. Cichowski
, Brigham and Women's Hospital, Harvard Medical School, USA
Developing Combination Therapies with PI3K/mTOR Pathway Inhibitors
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 6
Hong Wu
, UCLA/IMED c/o Cyndi Haddad, USA
Cross-Talk between the PI3K and MAPK Pathways Determines Prostate Cancer Metastasis
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 5 of 6
Kira Gritsman
, Albert Einstein College of Medicine, USA
Short Talk: RAS-Mutated Myeloid Leukemias Are Dependent on the PI3 Kinase Isoform p110alpha
Wednesday, February 27
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 6 of 6
Maurizio Scaltriti
, Memorial Sloan-Kettering Cancer Center, USA
Short Talk: p90RSK Mediates Resistance to PI3K-Pathway Inhibitors in Breast Cancer
Wednesday, February 27
| 9:20AM - 9:40AM
Coffee Break
Room: Longs Peak Foyer
Wednesday, February 27
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Wednesday, February 27
| 11:00AM - 1:00PM
Poster Setup
Room: Quandary Peak
Wednesday, February 27
| 1:00PM - 10:00PM
Poster Viewing
Room: Quandary Peak
Wednesday, February 27
| 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer
Wednesday, February 27
| 5:00PM - 7:15PM
Insights from in vivo Experiments
Room: Longs Peak
Speaker 1 of 5
* M. Celeste Simon
, University of Pennsylvania, USA
Wednesday, February 27
| 5:00PM - 7:15PM
Insights from in vivo Experiments
Room: Longs Peak
Speaker 2 of 5
Tak W. Mak
, Campbell Family Institute for Breast Cancer, Canada
Tumor Metabolism: Insight from Mouse Models
Wednesday, February 27
| 5:00PM - 7:15PM
Insights from in vivo Experiments
Room: Longs Peak
Speaker 3 of 5
Yanping Zhang
, University of North Carolina at Chapel Hill, USA
The RP-Mdm2-p53 Pathway Links Nutrient Restriction to Lipid Homeostasis
Wednesday, February 27
| 5:00PM - 7:15PM
Insights from in vivo Experiments
Room: Longs Peak
Speaker 4 of 5
Ralph J. DeBerardinis
, University of Texas Southwestern Medical Center, USA
Measuring Metabolism and Metabolites in vivo
Wednesday, February 27
| 5:00PM - 7:15PM
Insights from in vivo Experiments
Room: Longs Peak
Speaker 5 of 5
Norman Koglin
, Piramal Imaging GmbH, Germany
PET Imaging of Glutamate/Cystine Transporter Activity in Cancer Patients
Wednesday, February 27
| 5:00PM - 7:00PM
PI3K Pathway: Cross-Talk, Feedback, Scaffold (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 5
*
Christian Rommel
, F. Hoffmann-La Roche Ltd, Switzerland
Wednesday, February 27
| 5:00PM - 7:00PM
PI3K Pathway: Cross-Talk, Feedback, Scaffold (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 5
Julian H. Downward
, Cancer Research UK, UK
Links between RAS Family GTPases and PI3K Signaling
Wednesday, February 27
| 5:00PM - 7:00PM
PI3K Pathway: Cross-Talk, Feedback, Scaffold (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 5
Peter K. Vogt
, The Scripps Research Institute, USA
The PI3K Pathway in Cancer
Wednesday, February 27
| 5:00PM - 7:00PM
PI3K Pathway: Cross-Talk, Feedback, Scaffold (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 5
Pier Paolo Pandolfi
, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Role of Mutant PTEN in Tumorigenesis
Wednesday, February 27
| 5:00PM - 7:00PM
PI3K Pathway: Cross-Talk, Feedback, Scaffold (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 5 of 5
John P. O'Bryan
, Medical University of South Carolina, USA
Short Talk: PI3KC2beta: Role in Tumorigenesis and Regulation by Nucleotide-Ras (nf-Ras)
Wednesday, February 27
| 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Quandary Peak
Wednesday, February 27
| 7:30PM - 10:00PM
Poster Session 3
Room: Quandary Peak
Thursday, February 28
| 7:00AM - 8:00AM
Breakfast
Room: Quandary Peak
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 1 of 7
* Jacques Pouysségur
, University of Nice, France
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 2 of 7
Bing Lim
, Genome Institute of Singapore, Singapore
Targeting Glycine Metabolism for Cancer Therapy
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 3 of 7
Susan E. Critchlow
, AstraZeneca, UK
Targeting Lactate Metabolism in Cancer
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 4 of 7
Sally A. Kornbluth
, Duke University Medical Center, USA
Metabolic Control of Caspase 2-Mediated Cell Death
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 5 of 7
Joan S. Brugge
, Harvard Medical School, USA
Use of 3D Culture Models to Understand the Impact of Targeted Therapy on Metabolism
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 6 of 7
Georgia Hatzivassiliou
, Genentech, Inc., USA
Short Talk: Dissecting the Role of Glutaminase in Cancer
Thursday, February 28
| 8:00AM - 11:00AM
Targeting Metabolism
Room: Longs Peak
Speaker 7 of 7
Genshi Zhao
, Eli Lilly and Company, USA
Short Talk: Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells: Metabolic Basis and Potential Clinical Implications
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 6
*
Bart Vanhaesebroeck
, University College London, Cancer Institute, UK
PI 3-Kinase Isoforms in Cancer and Metabolism
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 6
Davide Ruggero
, University of California, San Francisco, USA
Reprogramming Translational Control of mRNA Networks in Cancer and its Therapeutic Implications
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 6
Jonathan R. Hart
, The Scripps Research Institute, USA
Pulsed SILAC: Enabling the Direct Observation of Changes in Protein Synthesis Caused by mTOR Inhibition
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 6
William A. Weiss
, University of California, San Francisco, USA
Kinases in Autophagy as Therapeutic Targets in Brain Cancer
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 5 of 6
Vikki Flemington
, AstraZeneca, UK
Short Talk: Phosphatidylinositol-4-Kinase – Potent and Selective Inhibitors of Type III PI 4-Kinases
Thursday, February 28
| 8:00AM - 11:15AM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 6 of 6
Emilio Hirsch
, Fondazione per la Ricerca Biomedica – ONLUS, Italy
Short Talk: PI3K Class II alpha Controls Primary Cilium Function and Cell Proliferation in Development and Cancer
Thursday, February 28
| 9:00AM - 9:20AM
Coffee Break
Room: Longs Peak Foyer
Thursday, February 28
| 10:00AM - 10:00AM
On Own for Lunch and Recreation
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 1 of 6
* Kate Yen
, Auron Therapeutics, USA
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 2 of 6
Steve Colebrook
, Cancer Research UK, UK
A First-in-Man Phase I Trial of AZD3965, a Monocarboxylate Transporter 1 Inhibitor (MCT1), in Patients with Advanced Cancer
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 3 of 6
Krushna C. Patra
, Massachusetts General Hospital, Harvard Medical School, USA
Hexokinase 2 Is Required for Oncogenesis and its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 4 of 6
Alexandra R. Grassian
, Novartis Institutes for BioMedical Research, USA
Mutant Isocitrate Dehydrogenase Promotes a Reversible Epithelial-Mesenchymal Transition and Alters Metabolic Flux
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 5 of 6
Kelly E. Sullivan
, Cornell University, USA
Elucidating the Regulation of Mitochondrial Glutaminase in Cancer Progression
Thursday, February 28
| 3:00PM - 4:30PM
Workshop 2: Novel Therapeutic Approaches
Room: Longs Peak
Speaker 6 of 6
David R. Plas
, University of Cincinnati, USA
Transition to Fatty Acid Oxidation Mediates Survival of BCR-ABL-Transformed Cells after Inhibition of mTORC1-S6K1
Thursday, February 28
| 4:30PM - 5:00PM
Coffee Available
Room: Longs Peak Foyer
Thursday, February 28
| 5:00PM - 7:00PM
Influence of Metabolism on Epigenetic Regulation
Room: Longs Peak
Speaker 1 of 5
* Matthew G. Vander Heiden
, Massachusetts Institute of Technology, USA
Thursday, February 28
| 5:00PM - 7:00PM
Influence of Metabolism on Epigenetic Regulation
Room: Longs Peak
Speaker 2 of 5
Lewis C. Cantley
, Weill Cornell Medicine, USA
Metabolic Control of Histone Methylation
Thursday, February 28
| 5:00PM - 7:00PM
Influence of Metabolism on Epigenetic Regulation
Room: Longs Peak
Speaker 3 of 5
Kathryn E. Wellen
, University of Pennsylvania, USA
Use of Metabolic Pathways to Sense Cell State
Thursday, February 28
| 5:00PM - 7:00PM
Influence of Metabolism on Epigenetic Regulation
Room: Longs Peak
Speaker 4 of 5
Kate Yen
, Auron Therapeutics, USA
Mutation Selective IDH Inhibitors Mediate Histone and DNA Methylation Changes
Thursday, February 28
| 5:00PM - 7:00PM
Influence of Metabolism on Epigenetic Regulation
Room: Longs Peak
Speaker 5 of 5
Raul Mostoslavsky
, Harvard Medical School, USA
Short Talk: The Histone Deacetylase SIRT6 Suppresses Cancer Metabolism
Thursday, February 28
| 5:00PM - 7:00PM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 1 of 4
*
David A. Fruman
, University of California, Irvine, USA
Immune Effects of Anti-Cancer Drugs Targeting PI3K/mTOR
Thursday, February 28
| 5:00PM - 7:00PM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 2 of 4
Brendan D. Manning
, Harvard School of Public Health, USA
Linking Oncogenic Signaling to Anabolic Metabolism through mTOR
Thursday, February 28
| 5:00PM - 7:00PM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 3 of 4
Ramon Parsons
, Icahn School of Medicine at Mount Sinai, USA
PTEN Signaling
Thursday, February 28
| 5:00PM - 7:00PM
PI3K-Related Pathways (Preclinical)
This session is from PI 3-Kinase
Room: Grays Peak
Speaker 4 of 4
Ralph M. Fritsch
, Cancer Research UK London Research Institute, UK
Short Talk: RAS and RHO Family GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
Thursday, February 28
| 7:00PM - 7:30PM
Panel Discussion
Speaker 1 of 1
* Christian Rommel
, F. Hoffmann-La Roche Ltd, Switzerland
Thursday, February 28
| 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Quandary Peak
Thursday, February 28
| 8:00PM - 11:00PM
Entertainment
Room: Quandary Peak
Thursday, February 28
| 8:00PM - 11:00PM
Cash Bar
Room: Quandary Peak
Friday, March 01
| 10:23AM - 10:23AM
Departure
*Session Chair
†Invited, not yet responded.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##